促销时间表 uniQure
先进的时间表
简单图表
关于公司 uniQure
uniQure NV - компания, специализирующаяся на генной терапии. Он разрабатывает лечение и платформу для пациентов, страдающих генетическими и другими серьезными заболеваниями. Его продукты и услуги ориентированы на гемофилию, болезнь Хантингтона и сердечно-сосудистые заболевания. В сотрудничестве с Bristol Myers-Squibb компания сосредоточена на разработке линейки генных методов лечения сердечно-сосудистых заболеваний.| IPO date | 2007-06-20 |
|---|---|
| ISIN | NL0010696654 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://www.uniqure.com |
| Цена ао | 10.99 |
| 每日价格变化: | 0% (10.99) |
|---|---|
| 每周价格变化: | -18.05% (13.41) |
| 每月价格变化: | -30.44% (15.8) |
| 3个月内价格变化: | +82.56% (6.02) |
| 六个月内的价格变化: | +87.86% (5.85) |
| 每年价格变化: | +64.28% (6.69) |
| 3年内价格变化: | -36.29% (17.25) |
| 5年内价格变化: | -69.12% (35.59) |
| 10年价格变化: | -45.49% (20.16) |
| 年初以来价格变化: | -37.2% (17.5) |
|
|
低估
|
效率
|
|||||||||||||||||||||||||||||||||||||
股息
|
责任
|
成长冲动
|
|||||||||||||||||||||||||||||||||||||
| 机构 | 体积 | 分享, % |
|---|---|---|
| Nantahala Capital Management, LLC | 5916054 | 12.37 |
| Vestal Point Capital, LP | 3925000 | 8.2 |
| State Street Corporation | 3478872 | 7.27 |
| Blackrock Inc. | 1836696 | 3.84 |
| Morgan Stanley | 1759818 | 3.68 |
| 683 Capital Management LLC | 1693000 | 3.54 |
| Orbimed Advisors LLC. | 1347900 | 2.82 |
| Pictet Asset Management Holding SA | 1324246 | 2.77 |
| International Biotechnology Trust PLC | 1241500 | 2.6 |
| Schroder Investment Management Group | 1241500 | 2.6 |
| ETF | 分享, % | 本年盈利能力, % | 股息, % |
|---|---|---|---|
| Virtus LifeSci Biotech Clinical Trials ETF | 0.80858 | 63.04 | 0.33 |
| Global X Genomics & Biotechnology ETF | 0.412 | 2.58 | 0.15585 |
| ProShares UltraShort Nasdaq Biotechnology | 0.35 | -40.36 | 1.76 |
| Avantis U.S Small Cap Equity ETF | 0.02943 | 27.77 | 1.68271 |
| Invesco Nasdaq Biotechnology ETF | 0.02658 | 28.58 | 0.8565 |
| Principal Healthcare Innovators ETF | 0.02271 | 618.5 | 0.8416 |
| Future Tech ETF | 0.02271 | 426.34 | 0.8416 |
| Invesco FTSE RAFI US 1500 Small-Mid ETF | 0.02226 | 17.58 | 1.75869 |
| ProShares Ultra Nasdaq Biotechnology | 0.01858 | 51.7 | 0.85651 |
Schwab U.S. Small-Cap ETF
|
0.00652 | 17.47 | 1.51433 |
| Avantis U.S. Equity ETF | 0.00076 | 23.04 | 1.59151 |
Schwab U.S. Broad Market ETF
|
0.00043 | 24.86 | 1.43354 |
| 导师 | 职称 | 支付 | 出生年份 |
|---|---|---|---|
| Mr. Matthew Craig Kapusta | CEO & Executive Director | 1.16M | 1972 (53 年) |
| Mr. Christian Klemt | CFO, Principal Financial Officer & GM of Amsterdam Site | 566.36k | 1973 (52 年) |
| Prof. Hugo Katus | Chairman of Scientific Advisory Board and Managing Director of UniQure-Germany | N/A | |
| Ms. Maria E. Cantor | Chief Corporate Affairs Officer | 491.12k | 1968 (57 年) |
| Dr. Tamara Tugal Ph.D., MBA | Business Development Director | N/A | |
| Dr. Jeannette Potts J.D., Ph.D. | Chief Legal & Compliance Officer and Corporate Secretary | N/A | 1962 (63 年) |
| Mr. Richard Porter Ph.D. | Chief Business & Scientific Officer | N/A | 1968 (57 年) |
| Dr. Amin Abujoub Ph.D. | Chief Technical Operations | N/A | |
| Dr. Walid Abi-Saab M.D. | Chief Medical Officer | 1965 (60 年) | |
| Eileen Sawyer | Vice President of Global Medical Affairs |
地址: Netherlands, Amsterdam BP, Paasheuvelweg 25a - 在 Google 地图中打开, 打开 Yandex 地图
网站: http://www.uniqure.com
网站: http://www.uniqure.com
